Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete. It plans to distribute all or ...

MiniMed Group (MMED) has filed for a proposed Nasdaq IPO.

Medtronic (NYSE:MDT) announced today that its MiniMed Diabetes business filed with the SEC for a proposed initial public ...

TrumpRx: Discover how Trump's new agreements with major pharmaceutical companies aim to lower prescription drug costs for ...

Medtronic's MiniMed Group filed for an initial public offering in the United States on Friday, as the medical device maker ...

How a reporter began to investigate diabetes risk, and along the way, made a startling discovery about his own health.

Achieving remission from prediabetes appears to substantially lower the risk of cardiovascular death or hospitalization for heart failure decades later, according to global registry data.

Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

Worldwide health authorities have officially recognized a new form of diabetes that targets young and slim people. Dubbed ...

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

However, one significant problem has proven surprisingly durable: misdiagnosis of Type 1 diabetes (T1D). Estimates suggest ...

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...